Insys Therapeutics, Inc. — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b7349637-fcf9-4e1b-abde-6eaa64f27360/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2018 | $82.1M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007444 |
| FY 2017 | $140.7M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007444 |
| FY 2016 | $242.3M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007444 |
| FY 2015 | $330.3M | 2015-01-01 – 2015-12-31 | evidence 0001564590-17-005856 |
| FY 2014 | $219.1M | 2014-01-01 – 2014-12-31 | evidence 0001564590-17-005856 |
| FY 2013 | $99.3M | 2013-01-01 – 2013-12-31 | evidence 0001437749-14-003376 |
| FY 2012 | $15.5M | 2012-01-01 – 2012-12-31 | evidence 0001437749-14-003376 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Insys Therapeutics, Inc. — all facts · Net Income · Operating Income